Oct 13, 2021 06:45AM
Aug 3, 2021 06:25AM
May 19, 2021 05:00PM
Apr 11, 2021 02:00PM
Mar 10, 2021 04:30PM
Jan 29, 2021 06:20AM
Feb 15, 2019 09:23AM Lilly Completes Acquisition of Loxo Oncology
Jan 7, 2019 09:23AM
Jan 7, 2019 06:31AM
Jan 7, 2019 06:30AM
Jan 7, 2019 06:30AM
Dec 21, 2018 06:46AM
Dec 21, 2018 06:45AM
Nov 27, 2018 06:19AM Loxo Oncology (LOXO), Bayer Confirm FDA Approval of Vitrakvi for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion
Nov 26, 2018 07:16PM
Nov 26, 2018 04:51PM
Nov 13, 2018 08:58AM
Nov 8, 2018 06:45AM
Oct 22, 2018 06:19AM
Oct 21, 2018 05:12AM
Oct 21, 2018 05:12AM Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types
Oct 15, 2018 06:46AM
Oct 15, 2018 06:45AM
Oct 9, 2018 06:45AM
Oct 6, 2018 09:05AM
Sep 25, 2018 04:22PM
Sep 25, 2018 04:20PM
Sep 18, 2018 06:46AM Loxo Oncology (LOXO) Announces Accepted Abstracts at ATA
Sep 18, 2018 06:45AM
Sep 5, 2018 09:25AM
Sep 5, 2018 06:46AM
Sep 5, 2018 06:45AM
Aug 27, 2018 06:19AM
Aug 27, 2018 02:30AM
Aug 10, 2018 04:30PM Loxo Oncology (LOXO) Announces Accepted Abstracts at IASLC
Aug 10, 2018 04:30PM
Aug 9, 2018 06:49AM
Aug 9, 2018 06:45AM
Jun 4, 2018 09:30AM
May 29, 2018 06:47AM
May 29, 2018 06:45AM
May 29, 2018 06:45AM FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
May 18, 2018 06:19AM
May 8, 2018 06:45AM
Apr 16, 2018 09:23AM
Apr 10, 2018 06:45AM
Apr 10, 2018 06:45AM
Apr 10, 2018 06:45AM
Mar 26, 2018 06:46AM Loxo Oncology (LOXO) Completes Rolling Submission of NDA to FDA for Larotrectinib for Treatment of TRK Fusion Cancer
Mar 26, 2018 06:45AM

326,376 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All